Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

QBE Insurance Group (QBE.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-03-3011.6614.40Buy
2022-04-1411.8915.00Buy
2022-05-0512.6816.00Buy
2022-08-1112.5417.00Buy
2023-02-2014.9218.00Buy
2023-05-0115.4718.50Buy
2023-05-1214.6118.00Buy
2023-07-0715.5518.50Buy
2023-08-1015.4119.00Buy
2023-10-3115.6019.50Buy
2023-11-2715.6420.00Buy
2024-05-1317.5921.00Buy
2024-07-0117.0620.50Buy
2024-08-0916.0520.00Buy
2024-10-2917.2720.50Buy
2024-11-2719.7621.50Buy
2025-01-0219.4923.00Buy
2025-02-0120.9423.85Buy
2025-02-2120.6824.40Buy
2025-04-0222.2224.60Buy
2025-05-0521.3324.50Buy
2025-05-0922.5924.65Buy

Disclosures

  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.